Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment

Journal of Rheumatology

Volumn 29, Issue 12, 2002, Pages 2513-2520

  Paulus, Harold E ^a,b,c,d   Wiesner, Jason ^a,b,c   Bulpitt, Ken J ^a,b,c   Patnaik, Madhumita ^a,b,c   Law, Jacqueline ^a,b,c   Park, Grace S ^a,b,c   Wong, Weng Kee ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Specialty Laboratories   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti dsDNA antibody; Antinuclear antibody; Autoantibodies; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIRHEUMATIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; DNA ANTIBODY; DOUBLE STRANDED DNA; GOLD; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; DNA; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; DISABILITY; HEALTH STATUS; HOSPITALIZATION; IMMUNOLOGY; JOINT; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; QUESTIONNAIRE;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISABILITY EVALUATION; DNA; FEMALE; HEALTH STATUS; HUMANS; JOINTS; MALE; MIDDLE AGED; QUESTIONNAIRES; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 0036896034     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Charles PJ, Smeenk RJT, DeJong J, Feldman M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor-a. Findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43:2383-90.
2. Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski LL, Smolen JS. Induction of systemic lupus erythematosus by interferon-γ in a patient with rheumatoid arthritis. J Rheumatol 1991;18:1621-2.
3. Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178-83.
4. Preziati D, LaRosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995;132:587-93.
5. De Bandt M, Descamps V, Meyer O. Two cases of etanercept-induced lupus-like syndrome in RA patients [abstract]. Arthritis Rheum 2001;44 Suppl:S372.
6. Badot V, Servais G, Peretz A. Induction of antinuclear and anti-DNA antibodies in rheumatoid arthritis patient treated with infliximab [abstract]. Arthritis Rheum 2001:44 Suppl 9:S205.
7. Pisetsky DS. Tumor necrosis factor α blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum 2000;43:2381-2.
8. Jacob CO, McDevitt HO. Tumor necrosis factor-α in murine autoimmune `lupus' nephritis. Nature 1988;331:356-8.
9. Jacob CO. Tumor necrosis factor-α in autoimmunity: Pretty girl or old witch? Immunol Today 1992;13:122-5.
10. Parenti DL, Spencer-Green G. "Dear Healthcare Professional" Letter. Wyeth-Ayerst Laboratories/Immunex. October 10, 2000 [cited August 4, 2002]. Available at: http://www.wyeth.com/news/pdf/enbrelsafety.pdf.
11. van Oosten BW, Barkhof F, Truyen L, et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996;47:1531-4.
12. Amason BGW. TNF neutralization in MS. Results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Neurology 1999;53:457-65.
13. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Siegel JN. Demyelination diagnosed during etanercept (TNF receptor fusion protein) therapy [abstract]. Arthritis Rheum 2000;43 Suppl:S228.
14. Fox RL. Sjögren's syndrome. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of Rheumatology. Philadelphia: Saunders; 1997:955-68.
15. Pinals RS. Felty's Syndrome. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of Rheumatology. Philadelphia: Saunders; 1997:951-4.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Paulus HE, Bulpitt KJ, Ramos B, Park G, Wong WK. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis. Arthritis Rheum 2000;43:2743-50.
18. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
19. Specialty Laboratories. Year 2000: Directory of Services "Use and Interpretation of Tests" Books (CD-ROM). Santa Monica, CA: Specialty Laboratories; 2000.
20. Caulier M, Dromer C, Andrieu V, Le Guennec P, Fournie B. SSZ induced lupus in rheumatoid arthritis. J Rheumatol 1994;21:750-1.
21. Walker DJ, Griffiths M, Griffiths ID. Occurrence of autoimmune diseases and autoantibodies in multicase rheumatoid arthritis families. Ann Rheum Dis 1986;45:323-6.
22. Reichlin M, Harley JB. Antinuclear antibodies: an overview. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus. 5th Ed. Baltimore: Williams and Wilkins; 1997:398.
23. Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-11.
24. Clegg DO, Williams HJ, Singer JZ, et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991;18:1340-3.
25. Nishimura S, Nishiya K, Hisakawa N, et al. Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis. Acta Med Okayama 1996;50:261-5.
26. Juby AG, Davis P. Prevalence and disease associations of certain autoantibodies in elderly patients. Clin Invest Med 1998;21:4-11.
27. Saraux A, Allain J, Guedes C, et al. Clinical, laboratory and radiographic features of rheumatoid arthritis with and without nodules. Rev Rheum Engl Ed 1997;64:11-7.
28. Darwin BS, Grudier JP, Klatt CL, Pisetsky DS. IgG antinuclear antibodies with cross-reactive rheumatoid factor activity. J Immunol 1986;137:3796-801.